Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Inhalation & Nasal Sprays Generic Drugs Market Research Report by Indication, Age Group, Class, Route, Distrubution Channel, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Inhalation & Nasal Sprays Generic Drugs Market size was estimated at USD 6,392.52 million in 2020, is expected to reach USD 6,879.55 million in 2021, and is projected to grow at a CAGR of 7.95% reaching USD 10,119.95 million by 2026.
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage
This research report categorizes the Inhalation & Nasal Sprays Generic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Indication, the market was studied across Allergic Rhinitis, Asthma, and COPD.
Based on Age Group, the market was studied across Adults, Children 2 to 5, and Children 6 to 12.
Based on Class, the market was studied across Allergy Blocker, Anticholinergic, Antihistamine, Decongestants, Mast Cell inhibitors, and Nasal steroids.
Based on Route, the market was studied across Inhalation, Nasal Spray, and Tropical Lotion.
Based on Distribution Channel, the market was studied across Hospital Medical Store, Online Pharmacy, and Pharmacy Retail.
Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and the United Kingdom.
Altaire Pharmaceuticals Inc.
Beximco Pharmaceuticals Ltd
Catalent Pharma Solutions
Hikma Pharmaceuticals PLC
Navajo Manufacturing Company Inc.
Nephron Pharmaceuticals Corporation
Perrigo Company plc
Preferred Pharmaceuticals Inc.
Sandoz International GmbH
Sheffield Pharmaceuticals LLC
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Cumulative Impact of COVID-19
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Inhalation & Nasal Sprays Generic Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.
Key Topics Covered:
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
2. Research Methodology
3. Executive Summary
4. Market Overview
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.2.1. Low cost involved with generic prescription drugs
5.2.2. Increasing prevalence of asthma and COPD disorders
5.2.3. High healthcare cost in developed regions
5.3.1. Stringent regulations for generic drugs
5.4.1. Patent expiry of blockbuster drugs and increasing FDA approvals
5.4.2. Inclination towards generic medicines in developed countries due to increasing healthcare cost
5.5.1. Pricing pressure due to presence of multiple players in the segment
6. Inhalation & Nasal Sprays Generic Drugs Market, by Indication
6.2. Allergic Rhinitis
7. Inhalation & Nasal Sprays Generic Drugs Market, by Age Group
7.3. Children 2 to 5
7.4. Children 6 to 12
8. Inhalation & Nasal Sprays Generic Drugs Market, by Class
8.2. Allergy Blocker
8.6. Mast Cell Inhibitor
8.7. Nasal Steroid
9. Inhalation & Nasal Sprays Generic Drugs Market, by Route
9.3. Nasal Spray
9.4. Tropical Lotion
10. Inhalation & Nasal Sprays Generic Drugs Market, by Distribution Channel
10.2. Hospital Medical Store
10.3. Online Pharmacy
10.4. Pharmacy Retail
11. Americas Inhalation & Nasal Sprays Generic Drugs Market
12. Asia-Pacific Inhalation & Nasal Sprays Generic Drugs Market
13. Europe, Middle East & Africa Inhalation & Nasal Sprays Generic Drugs Market
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, by Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
For more information about this report visit https://www.researchandmarkets.com/r/374c1l
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900